|Last Price||Today's Change||52-Week Range||Trading Volume|
|91.62||-0.04 (-0.04%)||66.85 - 93.35||2.6 million (Below Avg)|
Market data as of 4:00PM 08/22/14. Quotes are delayed by at least 15 min.
Celgene Corporation to Present at Investor Conferences in September
08/21/2014 8:30 AM ET
Clinical Study in the Journal of Clinical Oncology Reports Patients with Diffuse Large B-Cell Lymphoma Receiving Oral REVLIMID with Standard R-CHOP Achieved 98% Overall Response Rate and 80% Complete Response Rate
08/19/2014 7:30 AM ET